Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) | PA 21 048

Frequently Asked Questions (FAQs): Ruth L. Kirschstein NRSA Individual Postdoctoral Fellowship (Parent F32) - PA-21-048

What is this funding opportunity?

This opportunity is the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32), Funding Opportunity Number (FOA) PA-21-048. It is an NIH fellowship program intended to support intensive, mentored research training for highly promising postdoctoral researchers.

What is the main goal of the Parent F32 fellowship?

The core goal is career development. NIH uses the F32 mechanism to help postdoctoral researchers build the scientific skills, publication record, and professional trajectory needed to become productive, independent investigators in health-related research areas that align with the missions of participating NIH Institutes and Centers.

Is the Parent F32 more about the research project or the training plan?

A major emphasis is that the application should be built around a strong training plan and exceptional mentorship, not just a good research idea. Applicants are evaluated not only on the proposed science, but also on the credibility of the training environment, the quality of mentorship, and the likelihood that the fellowship will accelerate the applicant toward an independent research career.

What kind of experience is the fellowship designed to support during the postdoc period?

The fellowship is designed to fund a postdoctoral period that clearly advances the applicant toward independence through guided research, career development activities, and a mentoring environment that is well matched to the applicant's goals.

Who is the sponsoring agency for this opportunity?

The opportunity is offered by the National Institutes of Health (NIH).

What general areas does this opportunity focus on?

It is described as a discretionary grant program with an education and health focus. The purpose is health-related research training aligned with the missions of participating NIH Institutes and Centers.

Does the Parent F32 allow the fellow to lead an independent clinical trial?

No. This Parent F32 announcement is specifically aimed at research training projects that do not include the fellow leading an independent clinical trial. The proposed fellowship research should not be structured around the applicant serving as the person responsible for designing and directing a clinical trial, a feasibility study for a clinical trial, or an ancillary clinical trial.

Can a fellow still work on research connected to a clinical trial?

Yes. The FOA allows a fellow to gain research experience within a clinical trial as long as the clinical trial is led by a sponsor or co-sponsor. In that case, the focus remains on training and mentored research rather than independent trial leadership.

Why does the clinical trial leadership restriction matter for applicants?

This distinction matters for applicants whose work touches clinical research. The fellowship can support meaningful involvement in clinical trial-related work, but it must be framed as mentored participation and training rather than the applicant leading the clinical trial.

Which NIH Institutes and Centers participate?

The opportunity references participating NIH Institutes and Centers, and eligibility and topic fit are tied to the missions of those participating components. The specific participating Institutes and Centers are not listed in the information provided here, so applicants should confirm alignment with the relevant NIH mission based on the active NIH posting.

What kinds of organizations are eligible to apply?

Eligibility is broad at the organizational level. Eligible organizations include public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (both 501(c)(3) and non-501(c)(3)); for-profit organizations other than small businesses; small businesses; and other organization types.

Are minority-serving institutions and tribal institutions explicitly included as eligible organizations?

Yes. The FOA explicitly calls out additional eligible applicant organizations such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs).

Are federal government agencies eligible to apply?

Yes. The FOA explicitly includes eligible federal government agencies among eligible applicant organizations.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The FOA explicitly includes non-U.S. entities (foreign organizations) as eligible applicant organizations.

Is this tied to specific CFDA numbers?

Yes. The opportunity is associated with multiple CFDA numbers across NIH components, reflecting that the parent announcement can be used for a range of health-related scientific fields depending on the participating institute or center.

When was this funding opportunity created, and what closing date is listed?

The funding opportunity was created on 2020-10-26, and the source data lists an original closing date of 2023-09-07.

Should applicants rely on the listed closing date?

Applicants should verify the current submission dates and cycles in the active NIH posting, since NIH FOAs often run on standard receipt dates and may be reissued or updated.

What is the most important theme reviewers will look for in an application?

Based on the description provided, a central theme is that the proposal should demonstrate intensive, mentored research training with a strong training plan and exceptional mentorship. The application should show that the fellowship will accelerate the applicant toward independence in a health-related research career.

How should an applicant frame the project if it involves clinical trial-related work?

If the proposed work touches a clinical trial, it should be framed as mentored participation and training within a clinical trial led by a sponsor or co-sponsor. It should not be framed as the fellow designing and directing the trial or serving as the person responsible for leading it.

What does it mean that this is a mentored postdoctoral training award?

It means the fellowship is intended to support a training experience guided by mentorship, where the applicant develops research skills and career readiness within a strong mentoring environment. The emphasis is on training, professional development, and positioning the fellow for an independent research career, rather than simply funding a standalone research project.

How does NIH describe the intended outcome of the fellowship?

The intended outcome is that the applicant builds the skills and track record needed to become a productive, independent investigator in a health-related field aligned with an NIH Institute or Center mission.